Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,157 public trials 307 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Recruiting

Epco, Zanu, Ritux for R/R FL or MZL

NCT06563596

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

NCT06441331

Conditions
CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
Locations
  • The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • Gustave Roussy Cancer Campus Villejuif, France
  • Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
View Trial Details
Recruiting

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

NCT02974647

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Miami Miami, Florida, United States
  • Northwestern Medicine (Data collection and specimen analysis) Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details
Recruiting

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

NCT04083495

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
  • Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Recruiting

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

NCT07015242

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • University Of Colorado Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 40 locations
View Trial Details

Related conditions